Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-98,441
Closed -$1.9M 1111
2024
Q4
$1.9M Sell
98,441
-27,490
-22% -$544K 0.01% 764
2024
Q3
$2.49M Sell
125,931
-200,065
-61% -$3.48M 0.01% 699
2024
Q2
$5.42M Buy
325,996
+9,892
+3% +$187K 0.02% 519
2024
Q1
$6.76M Buy
316,104
+103,345
+49% +$2.34M 0.02% 488
2023
Q4
$5.12M Buy
212,759
+72,759
+52% +$1.74M 0.02% 545
2023
Q3
$3.9M Sell
140,000
-15,400
-10% -$499K 0.01% 579
2023
Q2
$5.26M Hold
155,400
0.02% 544
2023
Q1
$6.35M Buy
155,400
+26,700
+21% +$1.02M 0.02% 508
2022
Q4
$4.33M Buy
128,700
+35,107
+38% +$1.2M 0.02% 637
2022
Q3
$3.07M Sell
93,593
-16,107
-15% -$610K 0.01% 680
2022
Q2
$4.23M Sell
109,700
-7,400
-6% -$311K 0.02% 623
2022
Q1
$5.7M Buy
117,100
+900
+0.8% +$41.5K 0.02% 610
2021
Q4
$5.24M Sell
116,200
-97,100
-46% -$3.99M 0.01% 653
2021
Q3
$8.92M Buy
213,300
+109,700
+106% +$4.63M 0.03% 531
2021
Q2
$4.48M Buy
+103,600
New +$4.49M 0.01% 737

Other funds holding NVST

Axa's NVST Position: Q1 2025 in Review

Axa sold out of Envista (NVST) in Q1 2025, closing a stake of 98,441 shares — an estimated $1.9M sold.

Axa first reported a position in NVST in Q2 2021 and held it in 15 quarters. The position peaked at $8.92M in Q3 2021. 288 funds tracked by Wall St. Rank hold NVST as of Q1 2025.

  • Axa reported no remaining Envista position as of Q1 2025 after selling out during the quarter.
  • Axa sold 98,441 Envista shares in Q1 2025, an estimated $1.9M.
  • Axa first reported a position in Envista in Q2 2021 and held it in 15 quarters.
  • Axa's Envista position peaked at $8.92M in Q3 2021.
  • 288 funds tracked by Wall St. Rank held Envista as of Q1 2025.

Based on Axa's 13F filing for Q1 2025, filed 15 May 2025.